speb/financial-data huggingface dataset:
VIG.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 5940320.00
VIG.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 10514.00
VIG.AX balance_sheet (annual, 2024-06-30) — Working Capital: 1180846.00
VIH1.DE income_statement (annual, 2021-12-31) — Basic Average Shares: 27644894.00
VIH1.DE income_statement (annual, 2021-12-31) — Basic EPS: 1.08
VIH1.DE cash_flow (annual, 2021-12-31) — Capital Expenditure: -126000.00
VIH1.DE cash_flow (annual, 2021-12-31) — Cash Dividends Paid: -16285000.00
VIH1.DE balance_sheet (annual, 2021-12-31) — Cash Financial: 68164000.00
VIH1.DE cash_flow (annual, 2021-12-31) — Common Stock Issuance: 4400000.00
VIH1.DE balance_sheet (annual, 2021-12-31) — Construction In Progress: 0.00
VIH1.DE balance_sheet (annual, 2021-12-31) — Current Debt: 59670000.00
VIH1.DE balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 59670000.00
VIH1.DE income_statement (annual, 2021-12-31) — Diluted Average Shares: 27644894.00
VIH1.DE income_statement (annual, 2021-12-31) — Diluted EPS: 1.08
VIH1.DE balance_sheet (annual, 2021-12-31) — Dividends Payable: 177000.00
VIH1.DE cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -108198000.00
VIH1.DE cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 4400000.00
VIH1.DE balance_sheet (annual, 2021-12-31) — Long Term Debt: 688067000.00
VIH1.DE balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 688067000.00
VIH1.DE cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 4400000.00
VIH1.DE balance_sheet (annual, 2021-12-31) — Net Debt: 679573000.00
VIH1.DE balance_sheet (annual, 2021-12-31) — Other Equity Interest: 2946429000.00
VIH1.DE balance_sheet (annual, 2021-12-31) — Other Non Current Assets: 97136000.00
VIH1.DE balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 6832762000.00
VIH1.DE income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -166000.00
VIH1.DE income_statement (annual, 2021-12-31) — Other Operating Expenses: 12138000.00
VIH1.DE cash_flow (annual, 2021-12-31) — Taxes Refund Paid: -6704000.00
VIH1.DE balance_sheet (annual, 2021-12-31) — Total Debt: 747737000.00
VIH1.DE income_statement (annual, 2022-12-31) — +Operating Expense: 42221000.00
VIH1.DE income_statement (annual, 2022-12-31) — +Total Revenue: 109854000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Accounts Payable: 800000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 2381000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -2818000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 299307000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -426000.00
VIH1.DE income_statement (annual, 2022-12-31) — Amortization: 20000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 20000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 254945000.00
VIH1.DE income_statement (annual, 2022-12-31) — Average Dilution Earnings: 0.00
VIH1.DE income_statement (annual, 2022-12-31) — Basic Average Shares: 28234027.00
VIH1.DE income_statement (annual, 2022-12-31) — Basic EPS: 1.90
VIH1.DE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 68164000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Capital Expenditure: -614000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Capital Stock: 33055000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 67826000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 67826000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -12372000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Cash Financial: 67826000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Change In Inventory: -32817000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 29648000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Change In Working Capital: -3169000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Changes In Cash: -5247000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Common Stock: 33055000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 713566000.00
VIH1.DE income_statement (annual, 2022-12-31) — Cost Of Revenue: 18290000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Current Assets: 368676000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Current Debt: 152047000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 152047000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Current Liabilities: 196227000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Deferred Tax: 113000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Depreciation: 31434000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 31454000.00
VIH1.DE income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 31454000.00
VIH1.DE income_statement (annual, 2022-12-31) — Depreciation Income Statement: 31434000.00
VIH1.DE income_statement (annual, 2022-12-31) — Diluted Average Shares: 28234027.00
VIH1.DE income_statement (annual, 2022-12-31) — Diluted EPS: 1.90
VIH1.DE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 53578000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Dividends Payable: 177000.00
VIH1.DE income_statement (annual, 2022-12-31) — EBIT: 74145000.00
VIH1.DE income_statement (annual, 2022-12-31) — EBITDA: 105599000.00
VIH1.DE cash_flow (annual, 2022-12-31) — End Cash Position: 67826000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Financing Cash Flow: -80284000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Free Cash Flow: 67198000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -372000.00
VIH1.DE income_statement (annual, 2022-12-31) — General And Administrative Expense: 3151000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 43034000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 2807000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Gross PPE: 13741000.00
VIH1.DE income_statement (annual, 2022-12-31) — Gross Profit: 91564000.00
VIH1.DE income_statement (annual, 2022-12-31) — Interest Expense: 12294000.00
VIH1.DE income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 12294000.00
VIH1.DE income_statement (annual, 2022-12-31) — Interest Income: 2910000.00
VIH1.DE income_statement (annual, 2022-12-31) — Interest Income Non Operating: 2910000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Interest Paid Cff: -12294000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Invested Capital: 1297212000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Investing Cash Flow: 7225000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Investment Properties: 1145908000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 17868000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Issuance Of Debt: 29925000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Long Term Debt: 583646000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 583646000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 29925000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -85302000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 17868000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Minority Interest: 31188000.00
VIH1.DE income_statement (annual, 2022-12-31) — Minority Interests: -1126000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Net Debt: 515820000.00
VIH1.DE income_statement (annual, 2022-12-31) — Net Income: 53578000.00
VIH1.DE income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 53578000.00
VIH1.DE income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 54704000.00
VIH1.DE income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 53578000.00
VIH1.DE income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 53578000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 54704000.00
VIH1.DE income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 54704000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -20000.00
VIH1.DE income_statement (annual, 2022-12-31) — Net Interest Income: -9384000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Net Investment Properties Purchase And Sale: -37936000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 19999000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -55377000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -55377000.00
VIH1.DE income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -9384000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 2073000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Net PPE: 10923000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 25182000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 670532000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 58590000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3192000.00
VIH1.DE income_statement (annual, 2022-12-31) — Normalized EBITDA: 105599000.00
VIH1.DE income_statement (annual, 2022-12-31) — Normalized Income: 53578000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Operating Cash Flow: 67812000.00
VIH1.DE income_statement (annual, 2022-12-31) — Operating Income: 49343000.00
VIH1.DE income_statement (annual, 2022-12-31) — Operating Revenue: 109854000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 33054587.00
VIH1.DE cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: 4909000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Other Current Assets: 43483000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 37048000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 43034000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Other Non Cash Items: 6905000.00
VIH1.DE income_statement (annual, 2022-12-31) — Other Operating Expenses: 13758000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Other Payable: 1568000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Other Properties: 6159000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Other Receivables: 41000.00
VIH1.DE income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Payables: 6981000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 151000.00
VIH1.DE income_statement (annual, 2022-12-31) — Pretax Income: 61851000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Properties: 7582000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: -304000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -20000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Purchase Of Investment: -5209000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Purchase Of Investment Properties: -37936000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Purchase Of PPE: -594000.00
VIH1.DE income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 18290000.00
VIH1.DE income_statement (annual, 2022-12-31) — Reconciled Depreciation: 31454000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Repayment Of Debt: -85302000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Retained Earnings: 381204000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Sale Of Investment: 25208000.00
VIH1.DE cash_flow (annual, 2022-12-31) — Sale Of PPE: 25776000.00
VIH1.DE income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 178000.00
VIH1.DE income_statement (annual, 2022-12-31) — Selling General And Administration: 3329000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Share Issued: 33054587.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Stockholders Equity: 713566000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Tangible Book Value: 670532000.00
VIH1.DE income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
VIH1.DE income_statement (annual, 2022-12-31) — Tax Provision: 7147000.00
VIH1.DE income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.12
VIH1.DE balance_sheet (annual, 2022-12-31) — Taxes Receivable: 0.00
VIH1.DE cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -7034000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Total Assets: 1586409000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Total Capitalization: 1297212000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Total Debt: 735693000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 744754000.00
VIH1.DE income_statement (annual, 2022-12-31) — Total Expenses: 60511000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 841655000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1217733000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 645428000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Total Tax Payable: 4436000.00
VIH1.DE balance_sheet (annual, 2022-12-31) — Working Capital: 172449000.00
VIH1.DE income_statement (annual, 2023-12-31) — +Operating Expense: 35891000.00
VIH1.DE income_statement (annual, 2023-12-31) — +Total Revenue: 108009000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Accounts Payable: 1790000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Accounts Receivable: 5328000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -3296000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 299307000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -165000.00
VIH1.DE income_statement (annual, 2023-12-31) — Amortization: 5142000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 5142000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 115358000.00
VIH1.DE income_statement (annual, 2023-12-31) — Average Dilution Earnings: 0.00
VIH1.DE income_statement (annual, 2023-12-31) — Basic Average Shares: 33054587.00
VIH1.DE income_statement (annual, 2023-12-31) — Basic EPS: 3.92
VIH1.DE cash_flow (annual, 2023-12-31) — Beginning Cash Position: 67826000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Capital Expenditure: -136000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Capital Stock: 33055000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 103305000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 103305000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Change In Inventory: 27635000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -24655000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Change In Working Capital: 2980000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Changes In Cash: 169685000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Common Stock: 33055000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Common Stock Equity: 844173000.00
VIH1.DE income_statement (annual, 2023-12-31) — Cost Of Revenue: 17944000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Current Assets: 461742000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 40038000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Current Liabilities: 58732000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Deferred Tax: 10664000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Depreciation: 23809000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 28951000.00
VIH1.DE income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 28951000.00
VIH1.DE income_statement (annual, 2023-12-31) — Depreciation Income Statement: 23809000.00
VIH1.DE income_statement (annual, 2023-12-31) — Diluted Average Shares: 33054587.00
VIH1.DE income_statement (annual, 2023-12-31) — Diluted EPS: 3.92
VIH1.DE income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 129604000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Dividends Payable: 177000.00
VIH1.DE income_statement (annual, 2023-12-31) — EBIT: 182275000.00
VIH1.DE income_statement (annual, 2023-12-31) — EBITDA: 211226000.00
VIH1.DE cash_flow (annual, 2023-12-31) — End Cash Position: 237736000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Financing Cash Flow: 182128000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Free Cash Flow: 74605000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 2600000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -108072000.00
VIH1.DE income_statement (annual, 2023-12-31) — General And Administrative Expense: 2279000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 37901000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 5493000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Gross PPE: 13868000.00
VIH1.DE income_statement (annual, 2023-12-31) — Gross Profit: 90065000.00
VIH1.DE income_statement (annual, 2023-12-31) — Interest Expense: 30576000.00
VIH1.DE income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 30576000.00
VIH1.DE income_statement (annual, 2023-12-31) — Interest Income: 17187000.00
VIH1.DE income_statement (annual, 2023-12-31) — Interest Income Non Operating: 17187000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Interest Paid Cff: -28376000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Invested Capital: 844173000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Investing Cash Flow: -87184000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Investment Properties: 1056049000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 80329000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Issuance Of Debt: 571491000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Long Term Debt: 887400000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 887400000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 571491000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -370250000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 80329000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Minority Interest: 32548000.00
VIH1.DE income_statement (annual, 2023-12-31) — Minority Interests: -1234000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Net Debt: 784095000.00
VIH1.DE income_statement (annual, 2023-12-31) — Net Income: 129604000.00
VIH1.DE income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 129604000.00
VIH1.DE income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 130838000.00
VIH1.DE income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 129604000.00
VIH1.DE income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 129604000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 130838000.00
VIH1.DE income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 130838000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -9000.00
VIH1.DE income_statement (annual, 2023-12-31) — Net Interest Income: -13389000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Net Investment Properties Purchase And Sale: -78246000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -502882000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 201241000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 201241000.00
VIH1.DE income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -13389000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 10397000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -1000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Net PPE: 10572000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 493954000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 806272000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 74642000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3070000.00
VIH1.DE income_statement (annual, 2023-12-31) — Normalized EBITDA: 211226000.00
VIH1.DE income_statement (annual, 2023-12-31) — Normalized Income: 129604000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Operating Cash Flow: 74741000.00
VIH1.DE income_statement (annual, 2023-12-31) — Operating Income: 54174000.00
VIH1.DE income_statement (annual, 2023-12-31) — Operating Revenue: 108009000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 33054587.00
VIH1.DE cash_flow (annual, 2023-12-31) — Other Cash Adjustment Outside Changein Cash: 225000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Other Current Assets: 6919000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 14180000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 37901000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Other Investments: 3972000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Other Non Cash Items: 9744000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Other Payable: 2403000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Other Properties: 6267000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Other Receivables: 91844000.00
VIH1.DE income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Payables: 4370000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 144000.00
VIH1.DE income_statement (annual, 2023-12-31) — Pretax Income: 151699000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Properties: 7601000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: -122000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -9000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Purchase Of Investment: -502882000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Purchase Of Investment Properties: -78246000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Purchase Of PPE: -127000.00
VIH1.DE income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 17944000.00
VIH1.DE income_statement (annual, 2023-12-31) — Reconciled Depreciation: 28951000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Repayment Of Debt: -370250000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Restricted Cash: 134431000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Retained Earnings: 510783000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
VIH1.DE cash_flow (annual, 2023-12-31) — Sale Of PPE: 494081000.00
VIH1.DE income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 177000.00
VIH1.DE income_statement (annual, 2023-12-31) — Selling General And Administration: 2456000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Share Issued: 33054587.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Stockholders Equity: 844173000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Tangible Book Value: 806272000.00
VIH1.DE income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
VIH1.DE income_statement (annual, 2023-12-31) — Tax Provision: 20861000.00
VIH1.DE income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.14
VIH1.DE balance_sheet (annual, 2023-12-31) — Taxes Receivable: 4557000.00
VIH1.DE cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -10227000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Total Assets: 1900566000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Total Capitalization: 844173000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Total Debt: 927438000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 876721000.00
VIH1.DE income_statement (annual, 2023-12-31) — Total Expenses: 53835000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1023845000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1438823000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 965113000.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Total Tax Payable: 0.00
VIH1.DE balance_sheet (annual, 2023-12-31) — Working Capital: 403010000.00
VIH1.DE income_statement (annual, 2024-12-31) — +Operating Expense: 150529000.00
VIH1.DE income_statement (annual, 2024-12-31) — +Total Revenue: 111613000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Accounts Payable: 7489000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 7489000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Accounts Receivable: 9066000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 9066000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -3569000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -3569000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 299307000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 299307000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1245000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1245000.00
VIH1.DE income_statement (annual, 2024-12-31) — Amortization: 5169000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 5169000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 0.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 0.00
VIH1.DE income_statement (annual, 2024-12-31) — Basic Average Shares: 33054587.00
VIH1.DE income_statement (annual, 2024-12-31) — Basic EPS: 1.09
VIH1.DE cash_flow (annual, 2024-12-31) — Beginning Cash Position: 237736000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Capital Expenditure: -230000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Capital Stock: 33055000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Capital Stock: 33055000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 124684000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 124684000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 124684000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 124684000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -1322000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Change In Inventory: -12668000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 19643000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Change In Working Capital: 6975000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Changes In Cash: -110367000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Common Stock: 33055000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Common Stock: 33055000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 878561000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 878561000.00
VIH1.DE income_statement (annual, 2024-12-31) — Cost Of Revenue: 22040000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Current Assets: 187174000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Current Assets: 187174000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Current Liabilities: 105503000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 105503000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Deferred Tax: -31969000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Depreciation: 134628000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 139797000.00
VIH1.DE income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 139797000.00
VIH1.DE income_statement (annual, 2024-12-31) — Depreciation Income Statement: 134628000.00
VIH1.DE income_statement (annual, 2024-12-31) — Diluted Average Shares: 33054587.00
VIH1.DE income_statement (annual, 2024-12-31) — Diluted EPS: 1.09
VIH1.DE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 36142000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Dividends Payable: 0.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Dividends Payable: 0.00
VIH1.DE income_statement (annual, 2024-12-31) — EBIT: 51677000.00
VIH1.DE income_statement (annual, 2024-12-31) — EBITDA: 191474000.00
VIH1.DE cash_flow (annual, 2024-12-31) — End Cash Position: 127369000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Financing Cash Flow: -445210000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Free Cash Flow: 90957000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -210000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -75564000.00
VIH1.DE income_statement (annual, 2024-12-31) — General And Administrative Expense: 5558000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Goodwill: 0.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Goodwill: 0.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 32769000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 32769000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 10311000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 10311000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Gross PPE: 13682000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Gross PPE: 13682000.00
VIH1.DE income_statement (annual, 2024-12-31) — Gross Profit: 89573000.00
VIH1.DE income_statement (annual, 2024-12-31) — Interest Expense: 34468000.00
VIH1.DE income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 34468000.00
VIH1.DE income_statement (annual, 2024-12-31) — Interest Income: 34265000.00
VIH1.DE income_statement (annual, 2024-12-31) — Interest Income Non Operating: 34265000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Interest Paid Cff: -34468000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Invested Capital: 878561000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Invested Capital: 878561000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Investing Cash Flow: 243656000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Investment Properties: 1323792000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Investment Properties: 1323792000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 80329000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Investmentsin Associatesat Cost: 80329000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Issuance Of Debt: 62000000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 62000000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -460513000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 80329000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 80329000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Minority Interest: 53410000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Minority Interest: 53410000.00
VIH1.DE income_statement (annual, 2024-12-31) — Minority Interests: -6949000.00
VIH1.DE income_statement (annual, 2024-12-31) — Net Income: 36142000.00
VIH1.DE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 36142000.00
VIH1.DE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 43092000.00
VIH1.DE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 36142000.00
VIH1.DE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 36142000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 43091000.00
VIH1.DE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 43091000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -37000.00
VIH1.DE income_statement (annual, 2024-12-31) — Net Interest Income: -203000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Net Investment Properties Purchase And Sale: -279944000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 72031000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -398513000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -398513000.00
VIH1.DE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -203000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -10907000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Net PPE: 10113000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Net PPE: 10113000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 451606000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 845792000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 845792000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 52092000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 52092000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3415000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3415000.00
VIH1.DE income_statement (annual, 2024-12-31) — Normalized EBITDA: 191474000.00
VIH1.DE income_statement (annual, 2024-12-31) — Normalized Income: 36142000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Operating Cash Flow: 91187000.00
VIH1.DE income_statement (annual, 2024-12-31) — Operating Income: -60956000.00
VIH1.DE income_statement (annual, 2024-12-31) — Operating Revenue: 111613000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 33054587.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 33054587.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Other Current Assets: 7065000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 7065000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 11971000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 11971000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 32769000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 32769000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Other Investments: 3972000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Other Investments: 3972000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Other Non Cash Items: 11559000.00
VIH1.DE income_statement (annual, 2024-12-31) — Other Operating Expenses: 853000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Other Payable: 4194000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Other Payable: 4194000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Other Properties: 5983000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Other Properties: 5983000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Other Receivables: 33340000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Other Receivables: 33340000.00
VIH1.DE income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Payables: 24323000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Payables: 24323000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 815000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 815000.00
VIH1.DE income_statement (annual, 2024-12-31) — Pretax Income: 17209000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Properties: 7699000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Properties: 7699000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 312000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -37000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Purchase Of Investment: -9018000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Purchase Of Investment Properties: -279944000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Purchase Of PPE: -193000.00
VIH1.DE income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 22040000.00
VIH1.DE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 139797000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Repayment Of Debt: -460513000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Restricted Cash: 2685000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 2685000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Retained Earnings: 545335000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 545335000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Sale Of Investment: 81049000.00
VIH1.DE cash_flow (annual, 2024-12-31) — Sale Of PPE: 451799000.00
VIH1.DE income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 219000.00
VIH1.DE income_statement (annual, 2024-12-31) — Selling General And Administration: 5777000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Share Issued: 33054587.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Share Issued: 33054587.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 878561000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 878561000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Tangible Book Value: 845792000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 845792000.00
VIH1.DE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
VIH1.DE income_statement (annual, 2024-12-31) — Tax Provision: -25883000.00
VIH1.DE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.15
VIH1.DE balance_sheet (annual, 2024-12-31) — Taxes Receivable: 10334000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 10334000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Total Assets: 1897478000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Total Assets: 1897478000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Total Capitalization: 878561000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 878561000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 931971000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 931971000.00
VIH1.DE income_statement (annual, 2024-12-31) — Total Expenses: 172569000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 965507000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 965507000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1710304000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 1710304000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 860004000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 860004000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Total Tax Payable: 12640000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 12640000.00
VIH1.DE balance_sheet (annual, 2024-12-31) — Working Capital: 81671000.00
VIH1.DE balance_sheet (quarterly, 2024-12-31) — Working Capital: 81671000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 7379000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 9881000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 299307000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 12962000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 33055000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 18537000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 18537000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Cash Financial: 18537000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Common Stock: 33055000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 905092000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Current Assets: 179428000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Current Debt: 115125000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 115125000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 174758000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 30199000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1936811000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Investment Properties: 1577437000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 80329000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 916594000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 916594000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 80329000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Minority Interest: 71978000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Net Debt: 1013182000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Net PPE: 9879000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 874893000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 67034000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 3405000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 33054587.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 74779000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 24988000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Other Investments: 3972000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Other Payable: 15593000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Other Receivables: 53106000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Payables: 34645000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 571948000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Share Issued: 33054587.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 905092000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 874893000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 10163000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Total Assets: 2138861000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1821686000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Total Debt: 1031719000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 977070000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1161791000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1959433000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 987033000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 11673000.00
VIH1.DE balance_sheet (quarterly, 2025-06-30) — Working Capital: 4670000.00
VIH1.DE income_statement (annual, 2025-12-31) — +Operating Expense: 91702000.00
VIH1.DE income_statement (annual, 2025-12-31) — +Total Revenue: 165533000.00
VIH1.DE balance_sheet (annual, 2025-12-31) — Accounts Payable: 6153000.00
VIH1.DE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 6153000.00
VIH1.DE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 22323000.00
VIH1.DE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 22323000.00
VIH1.DE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -3600000.00
VIH1.DE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -3600000.00
VIH1.DE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 299307000.00
VIH1.DE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 299307000.00
VIH1.DE balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1702000.00
VIH1.DE balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1702000.00
VIH1.DE income_statement (annual, 2025-12-31) — Amortization: 9534000.00
VIH1.DE cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 9534000.00
VIH1.DE balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 79829000.00
VIH1.DE balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 79829000.00
VIH1.DE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 127369000.00
VIH1.DE balance_sheet (annual, 2025-12-31) — Capital Stock: 33055000.00
VIH1.DE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 33055000.00
VIH1.DE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 13850000.00
VIH1.DE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 13850000.00
VIH1.DE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 13850000.00
VIH1.DE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 13850000.00
VIH1.DE cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -1322000.00
VIH1.DE cash_flow (annual, 2025-12-31) — Change In Inventory: -24084000.00
VIH1.DE cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 24213000.00
VIH1.DE cash_flow (annual, 2025-12-31) — Change In Working Capital: 129000.00
VIH1.DE cash_flow (annual, 2025-12-31) — Changes In Cash: -111412000.00
VIH1.DE balance_sheet (annual, 2025-12-31) — Common Stock: 33055000.00
VIH1.DE balance_sheet (quarterly, 2025-12-31) — Common Stock: 33055000.00
VIH1.DE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 958996000.00
VIH1.DE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 958996000.00
VIH1.DE income_statement (annual, 2025-12-31) — Cost Of Revenue: 28264000.00
VIH1.DE balance_sheet (annual, 2025-12-31) — Current Assets: 150358000.00
VIH1.DE balance_sheet (quarterly, 2025-12-31) — Current Assets: 150358000.00
VIH1.DE balance_sheet (annual, 2025-12-31) — Current Liabilities: 213758000.00
VIH1.DE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 213758000.00
VIH1.DE cash_flow (annual, 2025-12-31) — Deferred Tax: -9704000.00
VIH1.DE cash_flow (annual, 2025-12-31) — Depreciation: 32716000.00
VIH1.DE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 42250000.00
VIH1.DE income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 42250000.00
VIH1.DE income_statement (annual, 2025-12-31) — Depreciation Income Statement: 32716000.00
VIH1.DE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 81444000.00
VIH1.DE income_statement (annual, 2025-12-31) — EBIT: 119783000.00
VIH1.DE income_statement (annual, 2025-12-31) — EBITDA: 162033000.00
VIH1.DE cash_flow (annual, 2025-12-31) — End Cash Position: 15957000.00
VIH1.DE cash_flow (annual, 2025-12-31) — Financing Cash Flow: -158483000.00
VIH1.DE cash_flow (annual, 2025-12-31) — Free Cash Flow: 87376000.00
VIH1.DE cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 309000.00
VIH1.DE cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -48586000.00
VIH1.DE income_statement (annual, 2025-12-31) — General And Administrative Expense: 33056000.00
VIH1.DE balance_sheet (annual, 2025-12-31) — Goodwill: 275905000.00
VIH1.DE balance_sheet (quarterly, 2025-12-31) — Goodwill: 275905000.00
VIH1.DE balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 402742000.00